← All clinician topics

CLINICIAN PVC & VT GUIDE · SECTION 3 OF 3

Treating PVCs & VT

Understand medications, catheter ablation, and sudden-death protection with an ICD.

Choose treatment by cause and goal

Address ischemia, heart failure, electrolyte abnormalities, and medication-related triggers. For reassuring low-burden ectopy, education and individualized trigger reduction may suffice. Persistent symptoms or ventricular dysfunction changes the discussion.[1][2]

Medications

Beta blockers can reduce symptoms and arrhythmia burden. Verapamil or diltiazem may help selected idiopathic rhythms in suitable patients; reduced EF and rhythm uncertainty limit their use. Flecainide and other antiarrhythmics require specialist selection, substrate assessment, and monitoring. Avoid class IC agents in prior MI/significant structural disease. Amiodarone has important organ toxicities; sotalol requires QT and renal assessment.[3]

Catheter ablation

EP mapping identifies a PVC focus or the circuit sustaining VT. Ablation targets that tissue to reduce recurrence. It is particularly useful for symptomatic idiopathic PVCs/VT and suspected PVC-induced cardiomyopathy; selected idiopathic rhythms can be treated with ablation first.

Scar-related reentry circuit in the left ventricle
One mechanism of monomorphic VT: an electrical circuit around ventricular scar. Not all VT is scar related.
Open full-size image →
Catheter targeting a scar-related VT circuit through a retrograde aortic approach
One illustrated access route for VT ablation. The actual approach depends on the location and substrate.
Open full-size image →

Scar-related VT ablation can reduce episodes and ICD therapies. Success, recurrence, and procedural risk depend on the substrate and location. Ablation usually complements an ICD when sudden-death protection remains indicated.[4][6]

When does an ICD enter the plan?

An ICD detects dangerous ventricular rhythms and delivers therapy. Transvenous systems may terminate VT with antitachycardia pacing before a shock.

Dual-chamber ICD with atrial and right ventricular defibrillator leads
A dual-chamber transvenous ICD example. Device choice follows the patient’s pacing and defibrillation needs.
Open full-size image →

Secondary prevention: survivors of VT/VF arrest or qualifying sustained VT without a reversible cause often need ICD evaluation.

Primary prevention: selected cardiomyopathy patients qualify before an arrest. EF ≤35% is a common threshold, but optimal therapy, symptoms, recovery/waiting periods, expected survival, and disease-specific risk also matter.

PVCs or incidental NSVT alone do not automatically justify an ICD. An ICD treats dangerous episodes; it does not eliminate their substrate.[7][8]

Acute VT treatment is rhythm specific

Unstable monomorphic VT with a pulse requires synchronized cardioversion. Pulseless VT/VF requires CPR and defibrillation. Sustained polymorphic VT requires an immediate unsynchronized shock.

For torsades recurrence, hospital care includes IV magnesium, correcting electrolytes, and removing QT-prolonging triggers; pause-dependent cases may need pacing. These measures must not delay a required shock.[5]

Follow-up and patient counseling

Reassess symptoms, PVC burden, and ventricular function after treatment. Provide an individualized emergency and driving plan. Repeated ICD shocks or a shock with syncope, chest pain, or persistent symptoms warrants emergency care; a single shock with full recovery still requires prompt device-team contact.